Gonzalez cancer therapy

Gonzalez cancer therapy Developed by Nicholas Gonzalez, M.D. (now deceased), this therapy is described in terms of proteolytic enzymes, and involves diet, supplements, and detoxification. A contact in New York City is Michelle Gabay, RN, at 212-305-9468, with a Web site located at http //www.dr-gonzalez.com/. 

Segura-Pacheco, B., Trejo-Becerril, C., Perez-Cardenas, E., Taja-Chayeb, L., Mariscal, I., Chavez, A., Acuna, C., Salazar, A.M., Lizano, M. and Duenas-Gonzalez, A. (2003) Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy. Clinical Cancer Research, 9, 1596-1603. 

J. Gonzalez, M.D., and two of his cancer patients, with a brief description of his cancer therapy, which notably involved coffee enemas and the consumption of 150 assorted but unspecified pills each day. It would have been informative, if time had allowed, to interview such as A. Hoffer, M.D., Ph.D., and Stanislaw R. Burzynski,... 

Blumenschein GR, Mills GB, Gonzalez-Angulo AM. Targeting the hepatoeyte growth factor-cMET axis in cancer therapy. J Clin Oncol. 2012 30 3287-96. 

Gonzalez-Larriba J, Garcia Carbonero I, Sastre Valera J, Perez Segura P, Diaz-Rubino E. Neoadjuvant therapy with cisplatin/fluorouracil vs cisplatin/UFT in locally advanced squamous cell head and neck cancer. Oncology (Huntingtj 1997 11(9 Suppl 10) 90-97. 

Gonzalez-Vitale JC, Hayes DM, Cvitkovic E, Sternberg SS. Acute renal failure after cis-dichlorodiammineplatinum(ll) and gen-tamicin-cephalothin therapies. Cancer Treat Rep 1978 62(5) 693-698. 

---